ARBs in combination of SGLT2i for diabetes mellitus

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 Apr 2026: Trial started, NCT07586371
  2. 14 May 2026: Trial registered, NCT07586371

The trials

NCT07586371: Proteinuria in Normotensive Diabetic Patients: ARBs Alone or in Combination of SGLT2i

State
Under way
Phase
Phase 2 and Phase 3
People
60 planned
Started
6 Apr 2026
Primary completion
5 Jul 2026
Arms
ARBs in combination of SGLT2i
Results
None posted
  1. 6 Apr 2026: Trial started
  2. 14 May 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.